> [Go to French version](/fr/Règlements/Décrets,%20ordonnances%20et%20règlements%20statutaires/95/31.md)

# Regulations Prescribing the Fees to be Paid by Certain Persons or Classes of Persons on Whom the Right or Privilege to Sell a Drug is Conferred by the Minister of National Health and Welfare by the Assignment of an Identification Number in Respect of the Drug

**SOR/95-31**

Enabling authorities: 
- [FINANCIAL ADMINISTRATION ACT](/en/Acts/Revised%20Statutes%20of%20Canada/F/F-11.md)

Date registered: 28 December 1994

----------

His Excellency the Governor General in Council, on the recommendation of the Minister of National Health and Welfare and the Treasury Board, pursuant to paragraph 19.1(1)(a)<sup><a href='#footnotea_e'>[*]</a></sup> of the [Financial Administration Act](/en/Acts/Revised%20Statutes%20of%20Canada/F/F-11.md), is pleased hereby to make the annexed Regulations prescribing the fees to be paid by certain persons or classes of persons on whom the right or privilege to sell a drug is conferred by the Minister of National Health and Welfare by the assignment of an identification number in respect of the drug.

<a name='footnotea_e'><sup>*</sup></a>: S.C. 1991, c. 24, s. 6<br />




## Short Title


**1** These Regulations may be cited as the Authority to Sell Drugs Fees Regulations.




## Interpretation


**2** 

- **(1)** In these Regulations,

***annual wholesale sales*** means the wholesale sales of a drug in the most recently completed fiscal year preceding the day on which a fee is required to be paid under these Regulations in respect of the drug; (*ventes en gros annuelles*)

***identification number*** means a number, preceded by the letters “DIN” or “GP”, that is assigned for a drug in accordance with subsection C.01.014.2(1) of the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md). (*identification numérique*)

- **(2)** All other words and expressions used in these Regulations have the meaning assigned to them by the [Food and Drugs Act](/en/Acts/Revised%20Statutes%20of%20Canada/F/F-27.md) or the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md).




## Fee


**3** 

- **(1)** This section applies to a person who has applied for an identification number for a drug of a type set out in column I of the schedule if
	- **(a)** an identification number has been assigned for the drug; and
	- **(b)** the person has submitted a notification under section C.01.014.3 of the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md) that the drug is being sold in Canada.

- **(2)** A person to whom this section applies shall pay, in respect of each drug referred to in subsection (1),
	- **(a)** the applicable fee set out in column II of the schedule, where the person’s annual wholesale sales of the drug in Canada are $20,000 or more; or
	- **(b)** a fee of $50, where the person’s annual wholesale sales of the drug in Canada are less than $20,000.

- **(3)** A fee referred to in subsection (2) shall be paid annually at the time the notification under section C.01.014.5 of the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md) is furnished to the Director, and is in respect of the 12-month period commencing on October 1 in the year in which it is required to be paid.

- **(4)** This section does not apply in respect of a drug if the identification number for the drug has been cancelled pursuant to the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md).




## Fee for the Transitional Period


**4** 

- **(1)** This section applies to a person who has applied for an identification number for a drug of a type set out in column I of the schedule if, on or before December 31, 1994,
	- **(a)** an identification number has been assigned for the drug; and
	- **(b)** the person has submitted a notification under section C.01.014.3 of the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md) that the drug is being sold in Canada.

- **(2)** A person to whom this section applies shall pay, in respect of each drug referred to in subsection (1),
	- **(a)** 75 per cent of the applicable fee set out in column II of the schedule, where the person’s annual wholesale sales of the drug in Canada are $20,000 or more; or
	- **(b)** a fee of $50, where the person’s annual wholesale sales of the drug in Canada are less than $20,000.

- **(3)** A fee referred to in subsection (2) shall be paid within 30 days after receipt of a demand for payment from the Director, and is in respect of the transitional period commencing on January 1, 1995 and ending on September 30, 1995.

- **(4)** This section does not apply in respect of a drug if, on or before December 31, 1994, the identification number for the drug has been cancelled pursuant to the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md).




## Proprietary Medicine


**5** Notwithstanding subsections 3(2) and 4(2), only one fee is payable in respect of two or more drugs that are proprietary medicines of a type set out under item 9 of the schedule if
- **(a)** a number, preceded by the letters “ GP ”, has been assigned for each drug; and
- **(b)** the drugs differ from each other only in flavour, fragrance or colour.




## Coming into Force


**6** These Regulations come into force on January 1, 1995.




### **SCHEDULE** 
**(Subsections 3(1) and (2) and 4(1) and (2))**
#### FEE
<table>
<tr>
<th></th>
<th>Column I</th>
<th>Column II</th>
</tr>
<tr>
<th>Item</th>
<th>Types of Drugs</th>
<th>Fee</th>
</tr>
<tr>
<td>1</td>
<td>Drugs listed in Schedule F to the [Food and Drug Regulations](/en/Regulations/Consolidated%20Regulations%20of%20Canada/801-900/C.R.C.,%20c.%20870.md)</td>
<td>$1,000</td>
</tr>
<tr>
<td>2</td>
<td>Drugs listed in Schedule D to the Act</td>
<td>1,000</td>
</tr>
<tr>
<td>3</td>
<td>Drugs listed in Schedule G to the Act</td>
<td>1,000</td>
</tr>
<tr>
<td>4</td>
<td>Drugs listed in the schedule to the Narcotic Control Act</td>
<td>1,000</td>
</tr>
<tr>
<td>5</td>
<td>Homeopathic drugs</td>
<td>250</td>
</tr>
<tr>
<td>6</td>
<td>Drugs labelled as being for veterinary use only</td>
<td>250</td>
</tr>
<tr>
<td>7</td>
<td>Drugs that are labelled as being for use as a disinfectant of medical devices</td>
<td>500</td>
</tr>
<tr>
<td>8</td>
<td>Drugs, other than those set out in item 7, that are labelled as being for use as a disinfectant</td>
<td>250</td>
</tr>
<tr>
<td>9</td>
<td>Drugs of a type that is not set out in items 1 to 8</td>
<td>500</td>
</tr>
</table>


